MedPath

nderstanding the role of therapeutic writing interventions as a treatment for adults experiencing post-traumatic stress

Not Applicable
Completed
Conditions
Posttraumatic Stress Symptoms (PTS)
Mental Health - Other mental health disorders
Registration Number
ACTRN12620001065987
Lead Sponsor
Australian National University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
83
Inclusion Criteria

Adults residing in Australia who have experienced a traumatic event that still distresses them (according to endorsement of at least one symptom of each B-E criteria on PCL-5).
Willingness to write about traumatic event in detail.
Willingness to be allocated randomly to one of three conditions.
If on medication, currently taking a stable dose for over a month.
; Adults residing in Australia who have experienced a traumatic event that still distresses them (according to endorsement of at least one symptom of each B-E criteria on PCL-5).
Willingness to write about traumatic event in detail.
Willingness to be allocated randomly to one of three conditions.
If on medication, currently taking a stable dose for over a month.

Exclusion Criteria

Currently undergoing psychotherapy elsewhere (no exclusion for past psychotherapy that has concluded).
Dissociative tendency.
Current alcohol or drug abuse.
Current suicidality.
History or current psychosis.
Likely to be inaccessible for the 3 weeks of writing.
Unable to write in English.
; Currently undergoing psychotherapy elsewhere (no exclusion for past psychotherapy that has concluded).
Dissociative tendency.
Current alcohol or drug abuse.
Current suicidality.
History or current psychosis.
Likely to be inaccessible for the 3 weeks of writing.
Unable to write in English.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in PTSD symptom severity as measured on the Post traumatic stress disorder checklist (PCL-5).[ Prior to writing session 1 (baseline), prior to writing session 2 (mid-intervention), prior to writing session 3 (mid-intervention), one-week post-intervention, and one-month follow-up.];Change in PTSD symptom severity as measured on the Post traumatic stress disorder checklist (PCL-5).[ Prior to writing session 1 (baseline), prior to writing session 2 (mid-intervention), prior to writing session 3 (mid-intervention), one-week post-intervention, and one-month follow-up.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath